News Archives - Page 244 of 722

FridaySep 09, 2022 10:30 am

Correlate Infrastructure Partners Inc. (CIPI) Aiding the Energy Transition; Looking to Grow Project Opportunities Over Time

Fossil fuels still account for about 80% of primary energy and 60% of electricity generation globally The recent Covid-19 pandemic, and Russia’s invasion of Ukraine, have shown the impact of overreliance on energy supplies, serving as a wake-up call for investors and governments to start making a transition from fossil fuels to more sustainable alternatives Correlate is at the forefront of pushing for this transition and is helping enterprises lower their dependence on fossil fuels while boosting their ESG goals It recognizes that there are approximately 6.8 million facilities in the U.S. commercial and industrial market that could benefit from…

FridaySep 09, 2022 9:45 am

Upgrades to Big Data Analysis Division Positions FingerMotion Inc. (NASDAQ: FNGR) for New Growth Era in China

U.S.-based communications technology services provider FingerMotion recently announced a number of milestones in its drive to make its Sapientus big data arm a powerful driver of analytics in China’s billion-strong consumer marketplace The company has recently focused development efforts on a ready-to-launch mobile device protection plan similar to AppleCare that the company expects to be competitive in China The announcement regarding Sapientus renews expectations that it will evolve beyond its core SMS and mobile top-up services, building on unique partnerships with China’s telecommunication giants and other global corporations The Sapientus updates include news that FingerMotion has reached a new agreement…

FridaySep 09, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Efforts to Combat GBM Brain Cancer Proceed Amid Competitive Field

CNS Pharmaceuticals, a Texas-based cancer drug developer, is advancing testing efforts for its lead drug candidates in the fight against glioblastoma (“GBM”) and other tumors Glioblastoma is an aggressive brain cancer that claims the lives of more than 10,000 Americans each year, with more victims worldwide, and it has no known cure CNS Pharmaceuticals’ efforts rely on establishing the safety and effectiveness of its lead candidate, Berubicin Berubicin is an anthracycline (chemotherapy agent) with the apparent ability to cross the blood-brain barrier to attack central nervous system tumors, which grants it a unique status among anthracyclines CNS has shown evidence…

ThursdaySep 08, 2022 10:30 am

GeoSolar Technologies Inc. Poised for Growth Amid Energy Crisis as US Consumers Seek Renewables and Government Steps in With Colossal Climate Legislation

Exciting times are ahead for solar as US Consumers seem hungry for more renewable energy and government introduces the largest-ever US climate investment As energy efficiency becomes priority, this game-changing legislation incentivizes consumers to invest in clean energy upgrades such as solar and wind; demand expected to rise and stay robust over the coming years GeoSolar stands ready to respond to this burgeoning market need with its unique system that integrates clean energy technologies such as solar power, geothermal ground-sourced energy and more Without a doubt, modern consumers seek to lead more sustainable lifestyles and play a meaningful role in…

ThursdaySep 08, 2022 9:45 am

Cepton, Inc.’s (NASDAQ: CPTN) Short-Range Lidar Nova Aims to Eliminate Blind Spots for Autonomous Vehicles; Plans to Exhibit Tech During IAA Transportation Conference

Cepton, in collaboration with ZKW Group GmbH, plans to showcase its Nova lidar headlamp integration into a ZKW heavy-duty truck headlamp at the IAA Transportation Conference (Sept. 20-25, 2022) Nova is an award-winning, miniature, wide field of view, near-range lidar sensor that provides high resolution 3D imaging in a compact form factor Nova integrates seamlessly around vehicles to provide 360-degree perception boosting blind spot detection, which is becoming a mandated vehicle safety feature The success of autonomous vehicles (“AV”) and advanced driver assistance systems (“ADAS”) hinges on technologies that make 360-degree intelligent perception possible. Cepton (NASDAQ: CPTN), a Silicon Valley…

ThursdaySep 08, 2022 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Names New CFO, Process for Ensuring Smooth Transition Amid Company’s Global Growth

Global cannabis brand-builder Flora Growth recently named a former Amazon financial executive as its new CFO Elshad Garayev will work with outgoing CFO Lee Leiderman to ensure a smooth transition of responsibility amid finalization of Flora’s mid-year financial filing with the SEC Flora Growth is headquartered in Canada with cultivation operations centered in Colombia, where recent government administrations have opened regulatory processes for exporting cannabis derivatives for the health and wellness markets The company continues to expand its operations internationally for sales in the UK and Europe generally, Australia, and throughout the Americas Global cannabis brand-builder Flora Growth (NASDAQ: FLGC)…

WednesdaySep 07, 2022 11:15 am

Odyssey Health, Inc. (ODYY) Receives Approval to Proceed with Cohort II of Its Phase I Trial’s Multiday Ascending Dosing Stage

Medical company Odyssey Health has received approval from the Safety Review Committee to start Cohort II of its Phase I trial’s Multiday Ascending Dosing (“MAD”) stage The approval follows evidence that Odyssey’s PRV-002 concussion drug candidate was safe and well-tolerated, as seen in Cohort I of the MAD stage The pharmacokinetic analysis also supports the hypothesis that more drug is getting to the brain itself, backing the company’s use of its patent-pending breath-propelled intranasal drug administration device The company believes that the intranasal drug/delivery combination will be instrumental in the success of the PRV-002 drug candidate in planned Phase II/III…

WednesdaySep 07, 2022 10:30 am

Correlate Infrastructure Partners Inc.’s (CIPI) CEO, Todd Michaels, Acknowledges the Company’s Organic Growth; Notes that it Has Never Been a Better Time for Business

Todd Michaels, Correlate’s Founder, President, and CEO, appeared on the latest episode of the Bell2Bell Podcast, where he talked about the company’s background, its achievements so far, and what lies ahead Mr. Michaels highlighted the opportunity in solar power generation, acknowledging that by 2050, it should account for around 40% of the actual overall capacity of energy generation in North America He also cited the Inflation Reduction Act, which adds incentives that are expected to help drive a significant leap forward for Correlate He was keen to point out that the company’s future looks bright and even maintained potential revenue…

WednesdaySep 07, 2022 9:45 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Posts Slight Q2 2022 Performance Improvement; Maintains Priorities and Focus on Advancing its Clinical Development Program for Berubicin

CNS reported a decrease in losses from $3.8 million in Q2 2021 to $3.6 million in Q2 2022, as well as a drop in research and development expenses from $2.7 million to $2.2 million, with an increase in general and administrative expenses from $1.1 million to $1.3 million The company closed the quarter with $9.0 million in cash, and a working capital of approximately $10.3 million which, it is confident, will fund its operations into the 2023 calendar year CNS looks to continue site initiations across the U.S., Italy, France, Spain, and Switzerland, while also pushing for regulatory and ethics…

WednesdaySep 07, 2022 9:00 am

FingerMotion Inc. (NASDAQ: FNGR) Benefitting From a First-Mover Advantage, and Relationships Forged in the Chinese Market

Martin Shen, FingerMotion’s CEO, noted the company’s shift in focus to pushing gross margins higher for the 2022 calendar year This has shaped the company’s initiatives that have seen the addition of the mobile device protection service for the Chinese market Since launching the service, FingerMotion has received $4 million in funding from Lind Global Fund II, LP, and is confident that this investment will yield the highest return, strengthen the company’s balance sheet, and enable it to experience transformational revenue growth over the next 12-24 months Mr. Shen has maintained that the current revenue is just “the tip of…

Site Search

Company Search

Category: News